Development and Use of Assay Conditions Suited to Screening for and Profiling of SET-Domain-Targeted Inhibitors of the MLL/SET1 Family of Lysine Methyltransferases. Assay and Drug Development Technologies, 2015 by Andrew Khouri | Jul 6, 2023
Functional characterization of a novel somatic oncogenic mutation of PIK3CB. Signal Transduction and Targeted Therapy, 2017 by Andrew Khouri | Jul 6, 2023
Cell lines expressing recombinant transmembrane domain-activated receptor kinases as tools for drug discovery. Journal of Biomolecular Screening, 2014 by Andrew Khouri | Jul 6, 2023
Establishment of a methodological platform for the exploration of MCL1 inhibitors by Andrew Khouri | Jul 6, 2023